A number of studies in recent years have confirmed this view and have suggested that baseline hs-CRP levels, racial differences, gender, individual factors such as having DM or CHD, and medication use may alter the link between serum Lp(a) levels and study endpoints [95–98]. The gene discussed is LPA; the disease is coronary artery disorder.